CG
Chenna Gundala
About Chenna Gundala
Data last updated:
Chenna Gundala has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Galoretx Pharmaceuticals Private Limited and Peptis Pharma Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Galoretx Pharmaceuticals Private Limited at ₹2.52 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2023 | 2018 | ₹2.52 Cr (FY 2024) | Active | |
| Designated Partner | 14 Jun 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chenna Gundala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chenna Gundala
Chenna Gundala has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Galoretx Pharmaceuticals Private Limited and Peptis Pharma Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Galoretx Pharmaceuticals Private Limited at ₹2.52 Cr (FY 2024).
Chenna Gundala is associated with 2 companies as Director and Designated Partner, including Galoretx Pharmaceuticals Private Limited (₹2.52 Cr), Peptis Pharma Llp.
Chenna Gundala has expertise in General Business.
Chenna Gundala has 5 years in corporate governance.
By reported revenue, the largest current company of Chenna Gundala is Galoretx Pharmaceuticals Private Limited, with revenue of ₹2.52 Cr (FY 2024).
Chenna Gundala currently holds positions at 2 companies: Galoretx Pharmaceuticals Private Limited (₹2.52 Cr), Peptis Pharma Llp.